Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Lee

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Frontiers in Pharmacology|October 10, 2022
Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytesMuluneh M Fashe, John K Fallon, Taryn A Miner, et al.
Journal of Pharmacological and Toxicological Methods|June 4, 2019
Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte modelRaju Khatri, John K Fallon, Rebecca J B Rementer, et al.
The American Journal of Cardiology|December 14, 2011
Relation between digital peripheral arterial tonometry and brachial artery ultrasound measures of vascular function in patients with coronary artery disease and in healthy volunteersCraig R Lee, Almasa Bass, Kyle Ellis, et al.
Circulation. Genomic and Precision Medicine|September 17, 2020
Effect of Gender on Clinical Outcomes in Patients Receiving <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionChelsea Gustafson, Megan N Gower, Alexis K Williams, et al.
American Heart Journal|July 10, 2003
Vasopressin: a new target for the treatment of heart failureCraig R Lee, Michael L Watkins, J Herbert Patterson, et al.
Pharmacogenetics and Genomics|June 7, 2012
Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humansEwa D Marczak, Jacqui Marzec, Darryl C Zeldin, et al.
Journal of the American College of Clinical Pharmacy : JACCP|August 6, 2021
How-To Guide for Overcoming Barriers of Research and Scholarship Training in Pharm.D. and Pharmacy Residency ProgramsKathryn A Morbitzer, Jacqueline E McLaughlin, Aaron S Devanathan, et al.
Frontiers in Pharmacology|July 21, 2023
Pregnancy related hormones increase CYP3A mediated buprenorphine metabolism in human hepatocytes: a comparison to CYP3A substrates nifedipine and midazolamMuluneh M Fashe, Taryn A Miner, John K Fallon, et al.
Frontiers in Cardiovascular Medicine|July 24, 2023
Antihypertensive medication use during pregnancy in a real-world cohort of patients diagnosed with a hypertensive disorder of pregnancyJulian E Garcia, Ian R Mulrenin, Anh B Nguyen, et al.
Circulation. Genomic and Precision Medicine|February 20, 2019
CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary InterventionAlexis K Williams, Melissa D Klein, Jesse Martin, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Frontiers in Pharmacology|October 10, 2022
Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytesMuluneh M Fashe, John K Fallon, Taryn A Miner, et al.
Journal of Pharmacological and Toxicological Methods|June 4, 2019
Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte modelRaju Khatri, John K Fallon, Rebecca J B Rementer, et al.
The American Journal of Cardiology|December 14, 2011
Relation between digital peripheral arterial tonometry and brachial artery ultrasound measures of vascular function in patients with coronary artery disease and in healthy volunteersCraig R Lee, Almasa Bass, Kyle Ellis, et al.
Circulation. Genomic and Precision Medicine|September 17, 2020
Effect of Gender on Clinical Outcomes in Patients Receiving <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionChelsea Gustafson, Megan N Gower, Alexis K Williams, et al.
American Heart Journal|July 10, 2003
Vasopressin: a new target for the treatment of heart failureCraig R Lee, Michael L Watkins, J Herbert Patterson, et al.
Pharmacogenetics and Genomics|June 7, 2012
Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humansEwa D Marczak, Jacqui Marzec, Darryl C Zeldin, et al.
Journal of the American College of Clinical Pharmacy : JACCP|August 6, 2021
How-To Guide for Overcoming Barriers of Research and Scholarship Training in Pharm.D. and Pharmacy Residency ProgramsKathryn A Morbitzer, Jacqueline E McLaughlin, Aaron S Devanathan, et al.
Frontiers in Pharmacology|July 21, 2023
Pregnancy related hormones increase CYP3A mediated buprenorphine metabolism in human hepatocytes: a comparison to CYP3A substrates nifedipine and midazolamMuluneh M Fashe, Taryn A Miner, John K Fallon, et al.
Frontiers in Cardiovascular Medicine|July 24, 2023
Antihypertensive medication use during pregnancy in a real-world cohort of patients diagnosed with a hypertensive disorder of pregnancyJulian E Garcia, Ian R Mulrenin, Anh B Nguyen, et al.
Circulation. Genomic and Precision Medicine|February 20, 2019
CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary InterventionAlexis K Williams, Melissa D Klein, Jesse Martin, et al.
Pageof 13